Retraction: ACADL functions as a tumor suppressor in hepatocellular carcinoma metastasis by inhibiting matrix metalloproteinase 14

Retraction: ACADL functions as a tumor suppressor in hepatocellular carcinoma metastasis by inhibiting matrix metalloproteinase 14

Saved in:

Bibliographic Details
Main Author:	Frontiers Editorial Office
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-12-01
Series:	Frontiers in Oncology
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1538134/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

RETRACTED: ACADL Functions as a Tumor Suppressor in Hepatocellular Carcinoma Metastasis by Inhibiting Matrix Metalloproteinase 14
by: Danfeng Guo, et al.
Published: (2022-01-01)

SIRT3 functions as a tumor suppressor in hepatocellular carcinoma
by: Xianchun Zeng, et al.
Published: (2017-03-01)

RELATIONSHIP BETWEEN EXPRESSION OF MATRIX METALLOPROTEINASES AND MORPHOLOGICAL HETEROGENEITY, TUMOR DIFFERENTIATION AND LYMPHOGENOUS METASTASIS OF SQUAMOUS CELL LARYNGEAL CARCINOMA
by: О. V. Savenkova, et al.
Published: (2016-02-01)

Metallothionein 1X is a tumor suppressor gene and inhibits oxidative stress and metastasis in renal cell carcinoma
by: Rui Rui, et al.
Published: (2025-08-01)

Retraction: Comprehensive circular RNA expression profile of lung adenocarcinoma with bone metastasis: identification of potential biomarkers
by: Frontiers Editorial Office
Published: (2025-06-01)

Selective Retention of an Inactive Allele of the DKK2 Tumor Suppressor Gene in Hepatocellular Carcinoma.
by: Yung-Feng Lin, et al.
Published: (2016-05-01)

Tumor Intrinsic Immunogenicity Suppressor SETDB1 Worsens the Prognosis of Patients with Hepatocellular Carcinoma
by: Chang-Qing Yin, et al.
Published: (2024-12-01)

Inhibition of matrix metalloproteinases: a troubleshooting for dentin adhesion
by: Izadora Quintela Souza de Moraes, et al.
Published: (2020-08-01)

Retraction: Nogo-C inhibits peripheral nerve regeneration by regulating Schwann cell apoptosis and dedifferentiation
by: Frontiers Editorial Office
Published: (2025-07-01)

Loss of tumor suppressor miR-126 contributes to the development of hepatitis B virus–related hepatocellular carcinoma metastasis through the upregulation of ADAM9
by: Le-yang Xiang, et al.
Published: (2017-06-01)

Retraction: Lycorine displays potent antitumor efficacy in colon carcinoma by targeting STAT3
by: Frontiers Editorial Office
Published: (2025-03-01)

Retraction: Bruton’s tyrosine kinase inhibition attenuates the cardiac dysfunction caused by cecal ligation and puncture in mice
by: Frontiers Editorial Office
Published: (2025-01-01)

Retraction: Histone methyltransferase SETD1A induces epithelial-mesenchymal transition to promote invasion and metastasis through epigenetic reprogramming of snail in gastric cancer
by: Frontiers Editorial Office
Published: (2025-06-01)

MATRIX METALLOPROTEINASES AND TISSUE INHIBITORS OF MATRIX METALLOPROTEINASES DURING PREGNANCY AND DELIVERY
by: Yu. V. Korenovsky, et al.
Published: (2012-09-01)

Matrix metalloproteinases and their inhibitors
by: O. S. Grigorkevich, et al.
Published: (2019-02-01)

Regulation of Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 in Abdominal Aortic Aneurysm
by: Shuo Wang, et al.
Published: (2023-09-01)

Study of matrix metalloproteinases and their tissue inhibitor in patients with ovarian tumors
by: K. P. Lactionov, et al.
Published: (2014-07-01)

Matrix Metalloproteinase 9 as Biomarker for Malignant Mammary Tumors in Dogs
by: Islam S Alani, et al.
Published: (2024-12-01)

Metastasis of hepatocellular carcinoma presented as a tumor of the maxillary sinus and retrobulbar tumor
by: Kolarević Daniela, et al.
Published: (2011-01-01)

Retraction: ErHuang formula improves renal fibrosis in diabetic nephropathy rats by inhibiting CXCL6/JAK/STAT3 signaling pathway
by: Frontiers Editorial Office
Published: (2024-12-01)

Inhibition of Hippocampal Matrix Metalloproteinase-3 and -9 Disrupts Spatial Memory
by: John W. Wright, et al.
Published: (2007-01-01)

Effects of matrix metalloproteinase inhibition in cultured human Tenon’s capsule fibroblasts
by: Na Hyun Kim, et al.
Published: (2025-07-01)

Peroxisome proliferator-activated receptor gamma coactivator-1 alpha acts as a tumor suppressor in hepatocellular carcinoma
by: Rui Liu, et al.
Published: (2017-04-01)

Retraction: Corrigendum: ErHuang formula improves renal fibrosis in diabetic nephropathy rats by inhibiting CXCL6/JAK/STAT3 signaling pathway
by: Frontiers Editorial Office
Published: (2024-12-01)

Immunohistochemical characterization of the expression of matrix metalloproteinase - 9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in the invasive endometrioid endometrial carcinoma
by: A. V. Chepets
Published: (2015-12-01)

Matrix metalloproteinase-7 and matrix metalloproteinase-9 expression is upregulated in congenital lung malformations
by: Ayşe Parlak, et al.
Published: (2025-02-01)

Tumor suppressor SLC9A2 inhibits colorectal cancer metastasis and reverses immunotherapy resistance by suppressing angiogenesis
by: Zizhen Zhang, et al.
Published: (2025-06-01)

Retraction: EZH2-mediated microRNA-375 upregulation promotes progression of breast cancer via the inhibition of FOXO1 and the p53 signaling pathway
by: Frontiers Editorial Office
Published: (2025-07-01)

Retraction: MiRNA-200b regulates RMP7-induced increases in blood-tumor barrier permeability by targeting RhoA and ROCKII
by: Frontiers Editorial Office
Published: (2025-07-01)

Retraction: Rosiglitazone exerts an anti-depressive effect in unpredictable chronic mild-stress-induced depressive mice by maintaining essential neuron autophagy and inhibiting excessive astrocytic apoptosis
by: Frontiers Editorial Office
Published: (2025-07-01)

Matrix Metalloproteinase-9 is associated with tumor microenvironment remodeling of bladder cancer
by: Fang Fang, et al.
Published: (2025-01-01)

Applications of Matrix Metalloproteinase-9-Related Nanomedicines in Tumors and Vascular Diseases
by: Xuying Li, et al.
Published: (2025-04-01)

Retraction: USP22 protects against myocardial ischemia–reperfusion injury via the SIRT1-p53/SLC7A11–dependent inhibition of ferroptosis–induced cardiomyocyte death
by: Frontiers Editorial Office
Published: (2025-06-01)

Matrix metalloproteinase 13 is induced in fibroblasts in polyomavirus middle T antigen-driven mammary carcinoma without influencing tumor progression.
by: Boye S Nielsen, et al.
Published: (2008-08-01)

NFATc1 is a tumor suppressor in hepatocellular carcinoma and induces tumor cell apoptosis by activating the FasL‐mediated extrinsic signaling pathway
by: Sanrong Xu, et al.
Published: (2018-09-01)

Impact of immunosuppressants on tumor pulmonary metastasis: new insight into transplantation for hepatocellular carcinoma
by: Jinyan Chen, et al.
Published: (2024-11-01)

Plectin-mediated cytoskeletal crosstalk as a target for inhibition of hepatocellular carcinoma growth and metastasis
by: Zuzana Outla, et al.
Published: (2025-03-01)

Luteoloside suppresses proliferation and metastasis of hepatocellular carcinoma cells by inhibition of NLRP3 inflammasome.
by: Shao-hua Fan, et al.
Published: (2014-01-01)

Hepatocellular Carcinoma: An Uncommon Metastasis in the Orbit
by: Maria-Nikoletta Protopapa, et al.
Published: (2020-01-01)

Rare Gingival Metastasis by Hepatocellular Carcinoma
by: Li-Jun Xue, et al.
Published: (2017-01-01)